Home SinuSys Corp. To Support Clinical Study Of New Steroid-Eluting Spacer Designed To Improve Sinus Surgery Outcomes
 

Keywords :   


SinuSys Corp. To Support Clinical Study Of New Steroid-Eluting Spacer Designed To Improve Sinus Surgery Outcomes

2015-02-04 06:58:30| drugdiscoveryonline Home Page

SinuSys Corp., an innovative sinus health company, recently announced commencement of a new clinical trial studying its proprietary drug-eluting spacer infused with steroids for use following functional endoscopic sinus surgery (FESS)

Tags: support designed study improve

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
18.05This Week in Agribusiness, May 18, 2024
18.05This Week in Agribusiness, May 18, 2024
More »